Health Canada requests that companies stop distributing ranitidine drugs while it assesses potential health risks

Wednesday, October 9, 2019

Health Canada has announced that at its request, the distribution of ranitidine drugs, which are used to treat heartburn – by prescription and over the counter – be stopped while Health Canada assesses a potential health risk. Students who use this drug are advised to consult with a pharmacist. For more information, visit Health Canada’s website.

According to the announcement: "The request to stop distribution means that the existing stock of ranitidine products currently available in pharmacies or at retail stores may continue to be sold. This is different from a recall, since products that are being recalled can no longer be sold."

For more detailed information and a complete list of affected products, please visit Health Canada’s website.

If you have concerns about potential complications, please contact Health Services at 519-888-4096.

  1. 2019 (27)
    1. October (6)
    2. September (2)
    3. August (2)
    4. July (1)
    5. June (2)
    6. May (3)
    7. April (5)
    8. March (1)
    9. February (3)
    10. January (2)
  2. 2018 (32)
    1. December (3)
    2. November (2)
    3. September (5)
    4. August (5)
    5. June (2)
    6. May (1)
    7. April (3)
    8. March (4)
    9. February (3)
    10. January (4)
  3. 2017 (22)
    1. December (4)
    2. October (1)
    3. September (2)
    4. August (2)
    5. July (5)
    6. June (4)
    7. May (1)
    8. April (1)
    9. February (1)
    10. January (1)